Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 1
1971 3
1972 2
1973 2
1974 1
1975 3
1976 4
1978 2
1979 5
1980 5
1981 2
1982 5
1983 5
1984 11
1985 9
1986 6
1987 5
1988 4
1989 7
1990 8
1991 5
1992 9
1993 9
1994 12
1995 19
1996 17
1997 12
1998 7
1999 18
2000 14
2001 17
2002 20
2003 27
2004 16
2005 24
2006 27
2007 22
2008 25
2009 21
2010 22
2011 24
2012 18
2013 27
2014 32
2015 30
2016 24
2017 28
2018 32
2019 21
2020 18
2021 20
2022 16
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

682 results

Results by year

Filters applied: . Clear all
Page 1
Budd-Chiari Syndrome.
Grus T, Lambert L, Grusová G, Banerjee R, Burgetová A. Grus T, et al. Prague Med Rep. 2017;118(2-3):69-80. doi: 10.14712/23362936.2017.6. Prague Med Rep. 2017. PMID: 28922103 Free article.
BCS can be classified according to etiology (primary, secondary), clinical course (acute, chronic, acute or chronic lesion), and morphology (truncal, radicular, and venooclusive type). ...
BCS can be classified according to etiology (primary, secondary), clinical course (acute, chronic, acute or chronic lesion), and morp …
The Budd-Chiari syndrome.
Hefaiedh R, Cheikh M, Marsaoui L, Ennaifer R, Romdhane H, Ben Nejma H, Bel Hadj N, Arfa N, Khalfallah MT. Hefaiedh R, et al. Tunis Med. 2013 Jun;91(6):376-81. Tunis Med. 2013. PMID: 23868034 Review.
This strategy has achieved 5-year survival rates approaching 70%. Medium-term prognosis depends on the severity of liver disease. CONCLUSION: The diagnosis of the Budd-Chiari syndrome must be considered in any patients with acute or chronic liver disease. ...
This strategy has achieved 5-year survival rates approaching 70%. Medium-term prognosis depends on the severity of liver disease. CON …
Splanchnic Vein Thrombosis.
Valla D. Valla D. Semin Thromb Hemost. 2015 Jul;41(5):494-502. doi: 10.1055/s-0035-1550439. Epub 2015 Jun 16. Semin Thromb Hemost. 2015. PMID: 26080307 Review.
Diagnosis depends on noninvasive imaging of the obstructed hepatic venous outflow tract. A spontaneously fatal course can be prevented by a stepwise approach: (1) anticoagulation therapy, specific therapy for underlying disease, and medical or endoscopic management of live …
Diagnosis depends on noninvasive imaging of the obstructed hepatic venous outflow tract. A spontaneously fatal course can be prevente …
Budd-Chiari syndrome: investigation, treatment and outcomes.
Goel RM, Johnston EL, Patel KV, Wong T. Goel RM, et al. Postgrad Med J. 2015 Dec;91(1082):692-7. doi: 10.1136/postgradmedj-2015-133402. Epub 2015 Oct 22. Postgrad Med J. 2015. PMID: 26494427 Review.
A third of patients require further intervention in addition to anticoagulation, commonly due to deteriorating liver function or patients identified as having a poorer prognosis. Prognostic scoring systems help guide treatment, but management is complex and patients …
A third of patients require further intervention in addition to anticoagulation, commonly due to deteriorating liver function or patients id …
Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
Valla DC. Valla DC. Hepatol Int. 2018 Feb;12(Suppl 1):168-180. doi: 10.1007/s12072-017-9810-5. Epub 2017 Jul 6. Hepatol Int. 2018. PMID: 28685257 Review.
This strategy results in a 5-year survival rate of nearly 85%. The medium-term prognosis depends upon the severity of liver disease, and the long-term outcome can be jeopardized by transformation of underlying conditions and hepatocellular carcinoma. ...
This strategy results in a 5-year survival rate of nearly 85%. The medium-term prognosis depends upon the severity of liver disease, …
Primary Budd-Chiari syndrome.
Valla DC. Valla DC. J Hepatol. 2009 Jan;50(1):195-203. doi: 10.1016/j.jhep.2008.10.007. Epub 2008 Oct 26. J Hepatol. 2009. PMID: 19012988 Free article. Review.
This strategy has achieved 5-year survival rates approaching 90%. Medium-term prognosis depends on the severity of liver disease. Long-term outcome might be jeopardized by transformation of underlying conditions and hepatocellular carcinoma....
This strategy has achieved 5-year survival rates approaching 90%. Medium-term prognosis depends on the severity of liver disease. Lon …
Budd-Chiari syndrome.
Hobbs KE. Hobbs KE. Lancet. 1992 Jan 11;339(8785):115-6. doi: 10.1016/0140-6736(92)91015-z. Lancet. 1992. PMID: 1345831 No abstract available.
Budd-Chiari syndrome.
Wang ZG, Jones RS. Wang ZG, et al. Curr Probl Surg. 1996 Feb;33(2):83-211. doi: 10.1016/s0011-3840(96)80001-3. Curr Probl Surg. 1996. PMID: 8595784 Review. No abstract available.
Primary Budd-Chiari syndrome versus sinusoidal obstruction syndrome: a review.
Lu F, Jia S, Lu H, Zhao H, Li Z, Zhuge Y, Romeiro FG, Mendez-Sanchez N, Qi X. Lu F, et al. Curr Med Res Opin. 2024 Feb;40(2):303-313. doi: 10.1080/03007995.2023.2288909. Epub 2024 Jan 24. Curr Med Res Opin. 2024. PMID: 38006404 Review.
Both of them can cause hepatic congestion with life-threatening complications, especially acute liver failure and chronic portal hypertension, and share some similar features in terms of imaging and clinical presentations, but they have heterogeneous risk factors, management stra …
Both of them can cause hepatic congestion with life-threatening complications, especially acute liver failure and chronic portal hypertensio …
682 results